Immunome (IMNM)
(Delayed Data from NSDQ)
$14.40 USD
-0.40 (-2.70%)
Updated May 16, 2024 04:00 PM ET
After-Market: $14.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 57.50% |
ABR | 1.00 |
Earnings ESP
|
-52.00% |
---|---|
Current Year | -1.72 |
Next Year | -2.43 |
EPS (TTM) | -1.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.00M | 4.00M | 8.52M | NA |
# of Estimates | 1 | 1 | 2 | NA |
High Estimate | 4.00M | 4.00M | 16.00M | NA |
Low Estimate | 4.00M | 4.00M | 1.03M | NA |
Year ago Sales | 4.26M | 3.57M | 14.02M | 8.52M |
Year over Year Growth Est. | -6.10% | 12.04% | -39.26% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.43 | -1.72 | -2.43 |
# of Estimates | 2 | 2 | 2 | 3 |
Most Recent Consensus | -0.18 | -0.21 | -2.19 | -2.53 |
High Estimate | -0.18 | -0.21 | -1.25 | -1.45 |
Low Estimate | -0.57 | -0.64 | -2.19 | -3.30 |
Year ago EPS | -0.46 | -0.36 | -1.31 | -1.72 |
Year over Year Growth Est. | 17.39% | -19.44% | -31.30% | -41.09% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 0 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.43 | -1.72 | -2.43 |
7 Days Ago | -0.36 | -0.41 | -1.72 | -2.36 |
30 Days Ago | -0.36 | -0.41 | -1.72 | -2.36 |
60 Days Ago | -0.22 | -0.25 | -1.92 | -1.74 |
90 Days Ago | -0.22 | -0.25 | -1.92 | -1.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.64 | -1.72 | -3.30 |
Zacks Consensus Estimate | -0.38 | -0.43 | -1.72 | -2.43 |
Earnings ESP | -52.00% | -50.59% | 0.00% | -35.99% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.54 | -0.36 | -0.46 | NA |
Estimate | -0.80 | -0.28 | NA | NA | NA |
Difference | 0.46 | -0.26 | NA | NA | 0.10 |
Surprise | 57.50% | -92.86% | NA | NA | -17.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more